{"SPADE_UN_11345": {"basic": {"SPADE ID": "SPADE_UN_11345", "Peptide Name": "Omiganan (MBI-226/MX-226/CLS001)", "Sequence": "ILRWPWWPWRRK", "Source": "Omiganan (MBI-226), an analogue of indolicidin, has been proven to be capable of significantly reducing catheter colonization and microbiologically confirmed tunnel infections during catheterization", "Biological Activity": ["Antibacterial"], "Target Organism": "[Ref.19524411]Omiganan was most active against staphylococci, with MICs of 2–4, 2–8, 4 and 4 μg/mL against MSSA, MRSA, MSSE and MRSE strains, respectively. The peptide was also inhibitory against other organisms, with MICs of 8–16 μg/mL against E. coli, E. faecalis and E. faecium (including VSE and VRE strains), 128 μg/mL against E. cloacae and S. marcescens and 64 μg/mL against C. albicans."}, "extended_data_url": "SPADE_UN_11345_extended.json"}}